GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Selling and Marketing Expense

Curocell (XKRX:372320) Selling and Marketing Expense : ₩ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Curocell's Selling and Marketing Expense for the six months ended in Jun. 2023 was ₩510.08 Mil. Curocell does not have enough years/quarters to calculate the Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023.


Curocell Selling and Marketing Expense Historical Data

The historical data trend for Curocell's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Selling and Marketing Expense Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
40.03 189.43 422.48 386.02 846.31

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense 218.03 167.99 510.08 336.23

Curocell Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.


Curocell Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Curocell's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines